Our Clinical Trials
About Marrow-Infiltrating Lymphocytes (MILs®)
Patients with cancer have cells in their bone marrow called memory T cells that can recognize, find and eliminate those cancer cells. WindMIL collects bone marrow containing these memory T cells through a short procedure that does not require hospitalization. Using WindMIL’s technology, the patient’s cells are converted and activated into marrow-infiltrating lymphocytes (MILs®) – a novel, cancer-fighting cell therapy. The MILs can potentially identify and kill the patient’s cancerous tumor.
Research suggests that MILs have the potential to recognize and treat numerous cancers including lung, bladder, breast, glioblastoma, head and neck, melanoma, prostate, renal cell (kidney), hepatocellular (liver) and others. WindMIL is working with cancer centers throughout the United States to develop MILs for the treatment of cancer.